In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments

Published:2019-12 Issue: Volume:20 Page:47-50
ISSN:2212-1099
Container-title:Value in Health Regional Issues
language:en
Short-container-title:Value in Health Regional Issues

Author:

Aguiar P.N.,Adashek Jacob J.,Roitberg Felipe,Noia Barreto Carmelia Maria,Del Giglio Auro,Lopes Gilberto L.

Publisher

Elsevier BV

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Reference16 articles.

1. The rising price of cancer drugs—a new old problem?;Prasad;JAMA Oncol,2019

2. Examining trends in cost and clinical benefit of novel anticancer drugs over time;Saluja;J Oncol Pract,2018

3. The high price of anticancer drugs: Origins, implications, barriers, solutions;Prasad;Nat Rev Clin Oncol,2017

4. A global comparison of the cost of patented cancer drugs in relation to global differences in wealth;Goldstein;Oncotarget,2017

5. Cost-effectiveness studies in oncology;Aguiar,2018

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant anti-PD1 immunotherapy of resected skin melanoma: an example of non-personalized medicine with no overall survival benefit;Critical Reviews in Oncology/Hematology;2024-10

2. Prevalence and factors affecting cancer medication nonadherence among patients on chemotherapy;International Journal of Noncommunicable Diseases;2023-10

3. Challenges and opportunities in building a health economic framework for personalized medicine in oncology;Personalized Medicine;2023-09

4. Challenges and Strategies for Improving Access to Cancer Drugs in Malaysia: Summary of Opinions Expressed at the 2nd MACR International Scientific Conference 2022;Cancer Management and Research;2023-08

5. Esterification of p-Coumaric Acid Improves the Control over Melanoma Cell Growth;Biomedicines;2023-01-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3